Pharmacy valuation in Germany for purchase and sale

Commission a pharmacy valuation: purpose, records and result

We first establish whether you are considering a purchase, sale or succession. The purpose determines the scope and records needed. Earnings are reviewed for exceptional items, owner dependence and transferable profitability; stock, lease commitments, staffing and investment requirements are assessed separately.

• Annual accounts, current management accounts and earnings changes
• Inventory, assets, lease terms and staffing structure
• Valuation date, transaction scope and intended handover

Deliverables and next steps

You receive a documented valuation with assumptions, adjustments, risks and scenarios. Business value, stock and additional funding needs remain separately identifiable. If a third party requires a formal report, its purpose, format and required standard are agreed before engagement.

Prepare a pharmacy purchase in Germany with valuation, due diligence, financing requirements, operating licence and a structured handover plan. Buy a pharmacy in Germany: valuation and handover →

Prepare a pharmacy sale in Germany: valuation, confidential business records, buyer assessment, succession and an organised handover. Sell a pharmacy in Germany: valuation and succession →

Implement a pharmacy QMS in Germany: review SOPs, document control, training and self-inspections with a practical plan for your team. Pharmacy QMS and quality management in Germany →

Match valuation to its purpose

Purchase, sale, succession and finance require transparent assumptions, risks and scenarios.

• Sustainable earnings
• Location and lease risks
• Inventory and working capital
• Value range and sensitivities

Distinguish valuation methods and deliverables

Forward-looking earnings and cash-flow scenarios form the core assessment. Market and asset evidence are used for plausibility, while inventory, fixed assets and working capital remain visible. The required deliverable—an initial value indication, a detailed decision paper or a formal expert opinion—is agreed before work starts.

• Earnings value and sustainable cash flow
• Market and asset plausibility
• Value indication or detailed report
• Clear boundary to legal, tax and statutory expert work

Agree process, documents and effort before starting

A confidential first discussion defines purpose, valuation date, sites, data room and required depth. Scope, timetable and fee can then be quoted responsibly.

• Purpose and recipients
• Data request and plausibility review
• Analysis, scenarios and value range
• Results discussion and next decisions

Review the business and location

We bring together trading data, prescription mix, footfall, competition, local healthcare environment and lease terms.

• Assess earnings, margin and cost base
• Location, competition and potential analysis
• Review premises, lease and development options

Control finance and risk

Purchase price, working capital, investment and liquidity are evaluated in a realistic start-up and transition scenario.

• Business plan and liquidity forecast
• Structured finance documentation
• Prioritised risks, requirements and open items

Execute the handover

We coordinate due diligence and operational transition alongside legal, tax and finance advisers.

• Licence and transition timeline
• Team and partner communication
• Stable procurement and supply from day one